Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/31/1996 | US5589174 Anti-human influenza virus antibody |
12/31/1996 | US5589173 Anticoagulants |
12/31/1996 | US5589154 Diagnosing presence of b-amyloid peptide |
12/31/1996 | CA2180280A1 Adenyl-cyclase-hemolysin (ac-hly)-protecting epitopes; use thereof for the treatment or the prevention of infections by bordetella |
12/31/1996 | CA2019745C Preparation for treating and preventing thromboses and thromboembolic complications, use of such a preparation and a method of producing the same |
12/31/1996 | CA1338824C Hypoglycemic and growth-promoting agent isolated from bacitracin |
12/31/1996 | CA1338818C Immunotoxins |
12/30/1996 | CA2180319A1 Modified bacterial alkaline phosphatases and use thereof |
12/27/1996 | WO1996042016A1 Use of a phycobiliprotein-binding peptide complex as a fluorescent tracer |
12/27/1996 | WO1996041891A1 Process for identifying secretory genes from helicobacter pylori |
12/27/1996 | WO1996041887A1 Dnase-active protein |
12/27/1996 | WO1996041885A1 Expression of human inducible nitric oxide synthase |
12/27/1996 | WO1996041884A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
12/27/1996 | WO1996041883A1 Plasmin-resistant streptokinase |
12/27/1996 | WO1996041882A1 Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof |
12/27/1996 | WO1996041881A1 Type f botulinum toxin and use thereof |
12/27/1996 | WO1996041880A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | WO1996041879A1 Camp factor of streptococcus uberis |
12/27/1996 | WO1996041878A1 Nucleic acid molecule and its uses in determining pathogenicity of staphylococcus |
12/27/1996 | WO1996041877A2 Malarial pre-erythrocytic stage polypeptide molecules |
12/27/1996 | WO1996041876A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | WO1996041875A1 p-53 BINDING PROTEIN CALLED Mdmx AND ENCODING SEQUENCES FOR SAID PROTEIN |
12/27/1996 | WO1996041865A1 Rapamcycin-based regulation of biological events |
12/27/1996 | WO1996041830A1 Cascade polymers with iodine-containing aromatic compounds |
12/27/1996 | WO1996041817A1 Collagen peptide fraction and its uses |
12/27/1996 | WO1996041816A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
12/27/1996 | WO1996041815A2 CONJUGATES OF αMSH WITH A FATTY ACID, PREPARATION METHOD THEREFOR, AND USE THEREOF AS A DRUG |
12/27/1996 | WO1996041814A1 Peptide, bronchodilator and blood flow ameliorant |
12/27/1996 | WO1996041640A1 Bradykinin analogs as selective thrombin inhibitors |
12/27/1996 | WO1996041624A1 TNF-α CONVERTING ENZYME |
12/27/1996 | WO1996041620A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | WO1996041607A2 Pharmaceutical compositions comprising restrictin p/activin a and use thereof as antagonist of il-6 and/or il-11 |
12/27/1996 | WO1996041606A2 Improved pharmaceutical compositions for gene therapy |
12/27/1996 | WO1996041529A1 Compositions and methods for use in controlling insect populations |
12/27/1996 | WO1996041523A1 Fgf9 as a specific ligand for fgfr3 |
12/27/1996 | WO1996035784A3 Chromatin-regulator genes |
12/27/1996 | WO1996035715A3 Pcna binding substance |
12/27/1996 | WO1996033214A3 Altered protein expression in hypoxic trophoblasts |
12/27/1996 | WO1996031607A3 Use of an 'immunodeficiency-virus suppressing lymphokine (isl)' to inhibit the replication of viruses, in particular of retroviruses |
12/27/1996 | EP0750044A2 DNA constructs and transfection of cells therewith for homologous recombination |
12/27/1996 | EP0750042A1 Exopolysaccarides-producing lactic acid bacteria |
12/27/1996 | EP0750041A2 HIV-2 nucleotide sequences |
12/27/1996 | EP0750040A2 Macrophage stimulating protein variant and method for producing the same |
12/27/1996 | EP0750039A1 Immunoregulatory protein LST-1 |
12/27/1996 | EP0750038A2 A mutant gene causing a defect in mitochondrial recombination and a method for its detection |
12/27/1996 | EP0750037A2 TNF-convertase and method measuring inhibition of TNF convertase |
12/27/1996 | EP0749980A1 Novel human ciliary neurotrophic factor |
12/27/1996 | EP0749979A2 Method and composition for treating thrombosis |
12/27/1996 | EP0749496A1 Human dna mismatch repair proteins |
12/27/1996 | EP0749495A1 Nucleic acid mutation detection in histologic tissue |
12/27/1996 | EP0749494A1 Compositions for the inhibition of tnf formation and uses thereof |
12/27/1996 | EP0749491A1 Enhanced expression in a plant plastid |
12/27/1996 | EP0749490A1 EXPRESSION OF $i(BACILLUS THURINGIENSIS CRY) PROTEINS IN PLANT PLASTIDS |
12/27/1996 | EP0749487A1 Cell surface protein and effector cell bonding reagent |
12/27/1996 | EP0749486A1 Diagnostic skin test for tuberculosis |
12/27/1996 | EP0749485A1 ANTIMICROBIAL PROTEINS FROM $i(ARALIA) AND $i(IMPATIENS) |
12/27/1996 | EP0749484A1 COORDINATE $i(IN VIVO) GENE EXPRESSION |
12/27/1996 | EP0749480A1 Novel forms of t cells costimulatory molecules and uses therefor |
12/27/1996 | EP0749479A1 Novel thiol protease inhibitor |
12/27/1996 | EP0749478A1 Yeast strains and modified albumins |
12/27/1996 | EP0749477A1 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
12/27/1996 | EP0749476A1 Mediators of chronic allograft rejection |
12/27/1996 | EP0749475A1 Use of the cytokine ip-10 as an anti-tumor agent |
12/27/1996 | EP0749472A1 Extracorporeal cell culture and transplantation kits |
12/27/1996 | EP0749444A1 Hybrid human/animal factor viii |
12/27/1996 | EP0749443A1 Fk-506 cytosolic binding protein |
12/27/1996 | EP0749442A1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES |
12/27/1996 | EP0749441A1 Expression and purification of cloned human alpha-fetoprotein |
12/27/1996 | EP0749435A1 Interference suppression agent for use in immuno assaying |
12/27/1996 | EP0749325A1 Bispecific molecules having clinical utilities |
12/27/1996 | EP0749323A1 Methods for modulating t cell unresponsiveness |
12/27/1996 | EP0749322A1 VACUOLATING TOXIN-DEFICIENT $i(H. PYLORI) AND RELATED METHODS |
12/27/1996 | EP0749319A1 Immortalized cells and uses therefor |
12/27/1996 | EP0749317A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
12/27/1996 | EP0749315A1 Induction of anti-tumor cytotoxic t lymphocytes in humans using synthetic peptide epitopes |
12/27/1996 | EP0749312A1 $i(DIROFILARIA IMMITIS) Gp29 PROTEINS, NUCLEIC ACID MOLECULES AND USES THEREOF |
12/27/1996 | EP0332651B2 Method of isolating ca 125 antigen |
12/27/1996 | CA2253496A1 Adherence gene from helicobacter pylori and polypeptide coded thereby |
12/27/1996 | CA2224567A1 Process for identifying secretory genes from helicobacter pylori |
12/27/1996 | CA2224229A1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells |
12/27/1996 | CA2224146A1 Improved pharmaceutical compositions for gene therapy |
12/27/1996 | CA2224089A1 Expression of human inducible nitric oxide synthase |
12/27/1996 | CA2224073A1 Means for detecting and preventing hiv infection involving use of receptors or binding sites capable of interacting with gp120 |
12/27/1996 | CA2222208A1 P-53 binding protein called mdmx and encoding sequences for said protein |
12/27/1996 | CA2221567A1 Factor ix binding peptides, derived from factor viii and their use as inhibitors of blood coagulation |
12/27/1996 | CA2221311A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
12/27/1996 | CA2221029A1 Malarial pre-erythrocytic stage polypeptide molecules |
12/27/1996 | CA2219080A1 Rapamycin-based regulation of biological events |
12/25/1996 | CN1138865A Peptides and methods against psoriasis |
12/25/1996 | CN1138864A New compsn. of glycoprotein isoforms having follicle stimulating |
12/25/1996 | CN1138863A Chimeric proteins which block complement activation |
12/25/1996 | CN1138632A Expression and secretion of hereologous proteins by yarrowia lipolytica transformants |
12/25/1996 | CN1138588A Phosphonomonoester nucleic acids, process for their preparation, and their use |
12/24/1996 | US5587490 Method of inactivation of viral and bacterial blood contaminants |
12/24/1996 | US5587468 High affinity nucleic acid ligands to HIV integrase |
12/24/1996 | US5587462 Corticotropin releasing factor; stimulates the secretion and biosynthesis of acth |
12/24/1996 | US5587460 Controller of cell differentiation; immunology |
12/24/1996 | US5587457 Neutrophil stimulating peptides |
12/24/1996 | US5587456 Hydrophobic attachment site for adhesion peptides |
12/24/1996 | US5587455 Hybrid protein comprising virus binding region from cd4 cellular receptor sequence linked to protein toxin sequence containing region essential for cell toxicity |